NL192430C - Farmaceutisch preparaat voor vertraagde toediening van kalium. - Google Patents

Farmaceutisch preparaat voor vertraagde toediening van kalium. Download PDF

Info

Publication number
NL192430C
NL192430C NL8100468A NL8100468A NL192430C NL 192430 C NL192430 C NL 192430C NL 8100468 A NL8100468 A NL 8100468A NL 8100468 A NL8100468 A NL 8100468A NL 192430 C NL192430 C NL 192430C
Authority
NL
Netherlands
Prior art keywords
microcapsules
potassium
capsule
weight
potassium chloride
Prior art date
Application number
NL8100468A
Other languages
English (en)
Dutch (nl)
Other versions
NL192430B (nl
NL8100468A (nl
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22572135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192430(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of NL8100468A publication Critical patent/NL8100468A/nl
Publication of NL192430B publication Critical patent/NL192430B/xx
Application granted granted Critical
Publication of NL192430C publication Critical patent/NL192430C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8100468A 1980-06-13 1981-01-30 Farmaceutisch preparaat voor vertraagde toediening van kalium. NL192430C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/159,335 US4259315A (en) 1980-06-13 1980-06-13 Controlled release potassium dosage form
US15933580 1980-06-13

Publications (3)

Publication Number Publication Date
NL8100468A NL8100468A (nl) 1982-01-04
NL192430B NL192430B (nl) 1997-04-01
NL192430C true NL192430C (nl) 1997-08-04

Family

ID=22572135

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100468A NL192430C (nl) 1980-06-13 1981-01-30 Farmaceutisch preparaat voor vertraagde toediening van kalium.

Country Status (13)

Country Link
US (1) US4259315A (OSRAM)
JP (1) JPS5714525A (OSRAM)
AU (1) AU544965B2 (OSRAM)
BE (1) BE886973A (OSRAM)
CA (1) CA1135624A (OSRAM)
CH (1) CH648206A5 (OSRAM)
DE (1) DE3100808A1 (OSRAM)
FR (1) FR2484254A1 (OSRAM)
GB (1) GB2077587B (OSRAM)
IL (1) IL61817A (OSRAM)
IT (1) IT1212512B (OSRAM)
NL (1) NL192430C (OSRAM)
PH (1) PH15605A (OSRAM)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
WO1985003436A1 (en) * 1984-02-10 1985-08-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
WO1986003121A1 (en) * 1984-11-27 1986-06-05 Sawruk Stephen D Tissue re-calcification product
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
US5932252A (en) * 1988-10-21 1999-08-03 The Regents Of The University Of California Method and composition for treatment of osteoporosis
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US5895662A (en) * 1997-12-31 1999-04-20 Meyer; Martha C. Meat product pet medicine capsule
NZ507951A (en) 1998-04-09 2002-12-20 Eurand Internat S Wettable microcapsules having hydrophobic polymer coated cores
US6506401B1 (en) 1999-01-28 2003-01-14 H. J. Heinz Company Filled edible product, and system and method for production of a filled edible product
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
AU2001257359A1 (en) 2000-04-27 2001-11-07 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
JP4689114B2 (ja) * 2000-11-02 2011-05-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビタミンと加工大蒜を含有するカプセル剤
US6780437B2 (en) * 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
CA2700480A1 (en) * 2007-09-28 2009-04-02 Lintec Corporation Orally-administered agent
US8974594B2 (en) * 2011-03-29 2015-03-10 Empire Technology Development Llc Microcapsule corrosion control in reinforced concrete
DE102017201095A1 (de) * 2017-01-24 2018-07-26 Henkel Ag & Co. Kgaa Tenside in Kapseln mit optimiertem Trübungspunkt
US12539314B1 (en) 2019-03-07 2026-02-03 Genus Lifesciences Inc. Aqueous oral compositions including potassium chloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415758A (en) * 1960-03-09 1968-12-10 Ncr Co Process of forming minute capsules en masse
DE2224256C2 (de) * 1972-05-18 1985-05-23 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Arzneimittelzubereitung
JPS5112919A (en) * 1974-07-19 1976-01-31 Smith Kline French Lab Johoseisoseibutsuno seiho
GB1422193A (en) 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet

Also Published As

Publication number Publication date
IL61817A (en) 1983-11-30
IT8167071A0 (it) 1981-01-22
DE3100808A1 (de) 1982-01-07
FR2484254B1 (OSRAM) 1983-06-10
AU544965B2 (en) 1985-06-27
BE886973A (fr) 1981-05-04
US4259315A (en) 1981-03-31
NL192430B (nl) 1997-04-01
CH648206A5 (fr) 1985-03-15
DE3100808C2 (OSRAM) 1990-07-26
GB2077587A (en) 1981-12-23
NL8100468A (nl) 1982-01-04
CA1135624A (en) 1982-11-16
GB2077587B (en) 1983-10-12
AU6589880A (en) 1981-12-24
PH15605A (en) 1983-02-28
JPH0260649B2 (OSRAM) 1990-12-17
IT1212512B (it) 1989-11-22
FR2484254A1 (fr) 1981-12-18
IL61817A0 (en) 1981-01-30
JPS5714525A (en) 1982-01-25

Similar Documents

Publication Publication Date Title
NL8100468A (nl) Farmaceutisch preparaat voor vertraagde toediening van kalium.
JP3194974B2 (ja) 標的制御釈放薬剤
EP0211946B1 (en) Controlled release potassium chloride
BRPI0721654A2 (pt) formas de dosagem sàlida compreendendo um revestimento entÉrico com liberaÇço acelerada do fÁrmaco
JPH0474339B2 (OSRAM)
CA2490145C (en) Use of a fast dissolving tablet of a proton pump inhibitor (ppi) to produce a liquid formulation for the treatment of gastrointestinal disorders
RU2181043C2 (ru) Фармацевтическая композиция для орального введения с модифицированным высвобождением, содержащая 5-аск, и способ лечения кишечных заболеваний
US11207276B2 (en) Multiparticulate L-menthol formulations and related methods
EP1203590B1 (en) Solid preparations containing chitosan powder and process for producing the same
DK165123B (da) Fremgangsmaade til mekanisk bearbejdning af cobalt-holdige metaller samt med vand blandbart koncentrat til brug ved fremgangsmaaden
JPH03145418A (ja) 塩基性薬物塩酸塩の徐放性製剤
US4104370A (en) Method of treating magnesium/potassium depletion
US4863743A (en) Controlled release potassium chloride
JPH0451528B2 (OSRAM)
US3784683A (en) Tablet preparation
Dashora et al. Development and characterization of pectin-prednisolone microspheres for colon targeted delivery
JP2939069B2 (ja) ニカルジピン持続性製剤とその製造方法
RU2152212C1 (ru) Лекарственная форма производных 5-нитроимидазола
Khidr et al. Development and in-vitro evaluation of sustained-release meclofenamic acid microspheres
WO2004004690A1 (en) Liquid dosage forms of proton pump inhibitors
HUT74741A (en) Microgranules of 5-nitro imidazole derivatives and pharmaceutical compositions containing them
Ingle et al. Formulation and Evaluation of Microspheres for Colon Targeted Drug Delivery Using Anthelminthics Drugs
MXPA99012101A (en) Solubilized sertraline compositions
CZ420399A3 (cs) Gastroretenční mikrosféry s regulovaným ulolňováním a zlepšenou dodávkou účinné látky
Rezaeifar Multiparticulate systems based on enteric polymers

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: AHP SUBSIDIARY (9) CORPORATION

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: ROBINS COMPANY, INCORPORATED. A.H. -

SNR Assignments of patents or rights arising from examined patent applications

Owner name: AMERICAN HOME PRODUCTS CORPORATION

V1 Lapsed because of non-payment of the annual fee

Effective date: 20000801